Abstract
Background
Blood infections with multidrug-resistant Gram-negative carbapenem-resistant bacilli are particularly dangerous and challenging to treat in organ transplant recipients. Resistance to carbapenems may be acquired, for example, in Enterobacteriaceae, Pseudomonas, or Acinetobacter spp. or innate, for example, in Stenotrophomonas maltophilia. The purpose of this study was to analyze blood infections caused by S maltophilia in organ transplant recipients and to compare drug susceptibility of these bacteria and the same species isolated from the blood of other inpatients.Methods
A total of 26 S maltophilia strains isolated from blood samples of 26 patients (including 14 liver or kidney transplant recipients) hospitalized during 2011 to 2014 were evaluated in this study. Antibiotic susceptibility was determined via E-test and disk diffusion methods.Results
Stenotrophomonas maltophilia strains isolated from blood exhibited sensitivity to trimethoprim/sulfamethoxazole (100%), levofloxacin (96.2%), ciprofloxacin (92.3%), ticarcillin/clavulanic acid (80.8%), and ceftazidime (53.9%).Conclusions
Because appropriate antibiotic therapy in the case of S maltophilia differs from the standard empirical therapy administered in the case of most other Gram-negative bacilli, early identification of this pathogen is of particular significance. The use of antibiotics to which this pathogen is sensitive eliminates the infection and helps avoid graft loss.Full text links
Read article at publisher's site: https://doi.org/10.1016/j.transproceed.2016.01.072
Citations & impact
Impact metrics
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/j.transproceed.2016.01.072
Article citations
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review.
Microorganisms, 11(6):1606, 17 Jun 2023
Cited by: 2 articles | PMID: 37375108 | PMCID: PMC10304660
Review Free full text in Europe PMC
Global prevalence and antibiotic resistance in clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis.
Front Med (Lausanne), 10:1163439, 05 May 2023
Cited by: 8 articles | PMID: 37215718 | PMCID: PMC10196134
Review Free full text in Europe PMC
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens.
Afr Health Sci, 16(1):149-152, 01 Mar 2016
Cited by: 19 articles | PMID: 27358626 | PMCID: PMC4915411
Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia: in vitro effects and clinical efficacy in cancer patients.
Int J Infect Dis, 58:18-21, 28 Feb 2017
Cited by: 11 articles | PMID: 28257816
Characteristics of Stenotrophomonas maltophilia infection in children in Sichuan, China, from 2010 to 2017.
Medicine (Baltimore), 99(8):e19250, 01 Feb 2020
Cited by: 7 articles | PMID: 32080131 | PMCID: PMC7034668
Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review.
J Antimicrob Chemother, 62(5):889-894, 28 Jul 2008
Cited by: 91 articles | PMID: 18662945
Review